Bluejay Diagnostics, Inc. Other Accounts Payable and Accrued Liabilities
Bluejay Diagnostics, Inc. (BJDX) had Other Accounts Payable and Accrued Liabilities of $1.80 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Payables and Accruals
us-gaap:OtherAccountsPayableAndAccruedLiabilities · last filed 2023-08-14
- 2023-06-30: Other Accounts Payable and Accrued Liabilities $1.80M.
- 2023-03-31: Other Accounts Payable and Accrued Liabilities $1.40M.
- 2022-12-31: Other Accounts Payable and Accrued Liabilities $1.60M.
| Period end | Other Accounts Payable and Accrued Liabilities |
|---|---|
| 2023-06-30 | $1.80M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.40M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.60M 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |